Invertebrate and fungal model organisms: emerging platforms for drug discovery

Area of Science:

• Biomedical research
• Genetics
• Pharmacology

Background:

• Translational research increasingly utilizes model organisms for human disease studies.
• Genetically tractable organisms offer flexible platforms for discovering drugs and their targets.
• Fungal yeast, nematode Caenorhabditis elegans, and fruit fly Drosophila melanogaster are key model systems.

Purpose of the Study:

• To review the integration of model organisms into chemical genomic drug discovery.
• To highlight recent advancements and applications in this field.
• To emphasize the expanding roles of these model systems.

Main Methods:

• Review of recent literature on model organism applications in drug discovery.
• Focus on chemical genomic approaches.
• Emphasis on yeast, C. elegans, and D. melanogaster.

Main Results:

• Model organisms are effectively used for small molecule and drug target discovery.
• Integration into chemical genomics accelerates the drug discovery pipeline.
• Novel disease models and high-throughput screening technologies enhance their utility.

Conclusions:

• Model organisms are indispensable tools in early-stage translational research.
• Their application in chemical genomics is vital for identifying new therapeutic strategies.
• Continued development of models and technologies will further expand their impact on drug discovery.